"Glutamine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A non-essential amino acid present abundantly throughout the body and is involved in many metabolic processes. It is synthesized from GLUTAMIC ACID and AMMONIA. It is the principal carrier of NITROGEN in the body and is an important energy source for many cells.
Descriptor ID |
D005973
|
MeSH Number(s) |
D12.125.068.330 D12.125.095.461 D12.125.154.424
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Glutamine".
Below are MeSH descriptors whose meaning is more specific than "Glutamine".
This graph shows the total number of publications written about "Glutamine" by people in this website by year, and whether "Glutamine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 2 | 3 | 5 |
1995 | 3 | 0 | 3 |
1996 | 3 | 1 | 4 |
1997 | 3 | 0 | 3 |
1998 | 5 | 2 | 7 |
1999 | 2 | 1 | 3 |
2000 | 4 | 1 | 5 |
2001 | 1 | 1 | 2 |
2002 | 0 | 1 | 1 |
2003 | 2 | 6 | 8 |
2004 | 0 | 4 | 4 |
2005 | 0 | 2 | 2 |
2006 | 4 | 1 | 5 |
2007 | 0 | 1 | 1 |
2008 | 2 | 3 | 5 |
2009 | 1 | 1 | 2 |
2010 | 1 | 3 | 4 |
2011 | 7 | 2 | 9 |
2012 | 2 | 3 | 5 |
2013 | 6 | 4 | 10 |
2014 | 4 | 4 | 8 |
2015 | 5 | 5 | 10 |
2016 | 3 | 6 | 9 |
2017 | 5 | 5 | 10 |
2018 | 2 | 5 | 7 |
2019 | 2 | 6 | 8 |
2020 | 0 | 1 | 1 |
2021 | 3 | 2 | 5 |
2022 | 2 | 9 | 11 |
2023 | 1 | 4 | 5 |
2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Glutamine" by people in Profiles.
-
Distinct Amino Acid Profile Characterizes Youth With or at Risk for Type 2 Diabetes. Diabetes. 2024 Apr 01; 73(4):628-636.
-
Untargeted metabolomic analysis investigating links between unprocessed red meat intake and markers of inflammation. Am J Clin Nutr. 2023 11; 118(5):989-999.
-
Plasma amino acid signatures define types of pediatric diabetes. Clin Nutr ESPEN. 2023 10; 57:21-28.
-
Targeting Glutamine Metabolism with a Novel Na+/K+-ATPase Inhibitor RX108 in Hepatocellular Carcinoma. Mol Cancer Ther. 2023 06 01; 22(6):693-705.
-
Targeting glutaminase is therapeutically effective in ibrutinib-resistant mantle cell lymphoma. Haematologica. 2023 06 01; 108(6):1616-1627.
-
Rewiring of the Host Cell Metabolome and Lipidome during Lytic Gammaherpesvirus Infection Is Essential for Infectious-Virus Production. J Virol. 2023 06 29; 97(6):e0050623.
-
In vivo characterization of glutamine metabolism identifies therapeutic targets in clear cell renal cell carcinoma. Sci Adv. 2022 12 16; 8(50):eabp8293.
-
Malignant transformation by oncogenic K-ras requires IDH2-mediated reductive carboxylation to promote glutamine utilization. Cancer Commun (Lond). 2023 02; 43(2):285-289.
-
Efficacy and Safety of Telaglenastat Plus Cabozantinib vs Placebo Plus Cabozantinib in Patients With Advanced Renal Cell Carcinoma: The CANTATA Randomized Clinical Trial. JAMA Oncol. 2022 10 01; 8(10):1411-1418.
-
Telaglenastat plus Everolimus in Advanced Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled, Phase II ENTRATA Trial. Clin Cancer Res. 2022 08 02; 28(15):3248-3255.